Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Renal Cell Carcinoma

Known as: Adenocarcinoma of the Kidney, Carcinoma, Renal Cell [Disease/Finding], rccs 
A carcinoma arising from the renal parenchyma. There is a strong correlation between cigarette smoking and the development of renal cell carcinoma… Expand
National Institutes of Health

Related topics

Related topics

49 relations
AldesleukinBlood supply aspectsCDISC SEND Tumor Findings Results TerminologyCISH gene
Expand

Broader (4)

CarcinomaKidney NeoplasmNeoplasmsRenal carcinoma

Narrower (4)

Chromophobe Renal Cell CarcinomaClear-cell metastatic renal cell carcinomaCollecting Duct Carcinoma of the KidneyThyroid Carcinoma, Papillary, With Papillary Renal Neoplasia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Next generation of immune checkpoint therapy in cancer: new developments and challenges
Immune checkpoints consist of inhibitory and stimulatory pathways that maintain self-tolerance and assist with immune response… Expand
  • figure 1
Is this relevant?
Review
2018
Review
2018
Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
With growing interest in cancer therapeutics, anti-angiogenic therapy has received considerable attention and is widely… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Review
2018
Review
2018
Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent…
BACKGROUND The randomised phase 2 CABOSUN trial comparing cabozantinib with sunitinib as initial therapy for advanced renal cell… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2017
Review
2017
New insights into the role of EMT in tumor immune escape
Novel immunotherapy approaches have provided durable remission in a significant number of cancer patients with cancers previously… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2017
Review
2017
Renal cell carcinoma
Renal cell carcinoma (RCC) denotes cancer originated from the renal epithelium and accounts for >90% of cancers in the kidney… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2017
Review
2017
Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor
Targeted immunotherapy has become the most promising approach for tumor patients. Programmed death-1 (PD-1), an inhibitory… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?
Review
2017
Review
2017
Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions.
In recent years, there has been dramatic expansion of the treatment armamentarium for patients with advanced renal cell carcinoma… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Review
2017
Review
2017
Treatment of renal cell carcinoma: Current status and future directions.
Answer questions and earn CME/CNE Over the past 12 years, medical treatment for renal cell carcinoma (RCC) has transitioned from… Expand
Is this relevant?
Review
2017
Review
2017
Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review
Background Immune checkpoint inhibitor (ICI) monoclonal antibodies (mAbs) targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2017
Review
2017
Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis.
The purpose of this meta-analysis was to provide clinical evidence regarding relationship between ADC and cellularity in… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE